Lupus is a chronic autoimmune disease that sees the body’s immune system attack its own tissues and organs. More common in women than men, it can inflame the skin, blood cells, joints, kidneys, brain, heart, and lungs.

Lupus is difficult to diagnose as its many symptoms may mimic those of other conditions. They may be mild or cause significant disability.

Some people are born with a tendency to develop lupus, but it can be triggered without warning by an infection, some prescription drugs or even sunlight. There is no cure, but treatments can manage the symptoms. 

Types of lupus

Risk factors

Signs, symptoms and diagnosis of lupus

Causes of lupus

Treatment of lupus

Our lupus research

Lupus is a difficult disease to diagnose and treat. Hudson Institute researchers are investigating improved ways to detect lupus, and treatments that may control its triggers and better target its symptoms.

Developing new treatments for lupus

Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson InstituteMolecular studies. New treatment. Associate Professor Michael Gantier and his team are investigating how localised tissue inflammation evolves into systemic lupus erythematosus (SLE), which sees the immune system attack normally healthy tissue. This disease involves the overproduction of interferons that are thought to drive its causes. A/Prof Gantier has identified factors that amplify interferon production and will attempt to exploit this to develop new treatments for lupus.

Lead Researcher | Associate Professor Michael Gantier

Preventing inflammation caused by lupus

Controlling the triggers that cause lupus

Lupus collaborators

Support for people with Lupus

Hudson Institute scientists cannot provide medical advice.
Find out more about Lupus.

Share this page